Aggarwal BB (2010).

Targeting inflammation-induced obesity and metabolic

disease by curcumin and other nutraceuticals. Annu Rev Nutr, 21(30): 173-
199.

Ana K (2007). Panduan Lengkap kesehatan Wanita. Yogyakarta: Gala Ilmu

Semesta.

Bachmeier BE, Mohrenz IV, Mirisola V, Schleicher E, Romeo F, Hohneke C,

Jochum M, Nerlich AG, Pfeffer U (2008). Curcumin downregulates the
inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.
Carcinogenesis, 29:779–89. [PubMed: 17999991]”

Chattopadhyay I, et al. (2004). Turmeric and curcumin: Biological actions and

medical applications. Current Science, 87(1): 44-53.

Chang LC, Kinghorn AD (2001). Flavonoid as Chemopreventive Agent, Boiactive

Compound from Natural Sources, Isolation, Characterization and
Biological Properties. New York: Tailor & Friends.

Chiu TL, Cheng SC (2009). Curcumin inhibits proliferation and migration by

increasing the Bax to Bcl-2 ratio and decreasing NF-KBp65 expression in
breast cancer MDA-MB-231 cells. Int J Mol Med, 23(4):469-75.

Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, Cheng AL
(2000). Curcumincontaining diet inhibits diethylnitrosamine-induced
murine hepatocarcinogenesis. Carcinogenesis, 21:331–5. [PubMed:
10657978]

Cho JW, Lee KS, Kim CW (2007). Curcumin attenuates the expression of IL-1β,
IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells NF-κB
and MAPKs as potential upstream targets. Int J Mol Med, 19(3): 469-74.

CRUK (2014). Worldwide cancer incidence statistics. Cancer Research UK.

http://www.cancerresearchuk.org/cancer-info/cancerstats/world/incidence/.
Diakses Januari 2015.
Demeule M, Levesque JM, Annabi B, Gingras D, Boivin D, Jodoin J, et al.
(2002). Green tea Cathechins as Novel Antitumor and antiangiogenic
Compounds. Curr.Med.Chem-Anticancer Agents, 2:441-463
Dewi L (2009). Kanker Payudara, mendeteksi gejala dini, pencegahan dan
pengobatan. Yogyakarta: Tugu Publisher.

Dona M, Dell’Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S

(2003). Neutrophil restraint by green tea: inhibition of inflammation,
associated angiogenesis, and pulmonary fibrosis. J Immunol, 170: 4335

Fujimura Y, Tachibana H, Yamamoto MM, Miyase T, Sano M, Yamada K

(2002). Antiallergic tea catechin, (-)-Epigallocatechin-3-O-(3-O-methyl)-
gallate, suppresses FcɛRI expression in human basophilic KU812 cells. J
Agric Food Chem, 50(20): 5729-5734.

Ganiswara SG (1995). Farmakologi dan Terapi. Jakarta: Bagian Farmakologi

Fakultas Kedokteran Universitas Indonesia, pp : 686-687

Hanahan D, Weinberg RA (2000). The Hallmarks of Cancer. Cell, 100: 57-70

Huang MT, Newmark HL, Frenkel K (1997). Inhibitory effects of curcumin on

tumorigenesis in mice. J Cell Biochem Suppl, 27:26–34. [PubMed:
9591190]

Holy JM (2002). Curcumin disrupts mitotic spindle structure and induces

micronucleation in MCF-7 breast cancer cells. Mutation Research/Genetic
Toxicology and Environmental Mutagenesis, 518(1):71-84.

Kakizoe T (2003). Chemoprevention of Cancer Focusing on Cinical Trial,

Nationa Cancer Center. Jpn.J.Clin.Oncol. 33(9): 421-442.

King RJB (2000. Cancer Biology, 2nd ed. London: Pearson Eduation Limited.

Lin YL, Lin JK (1997). (-)-Epigallocatechin-3-gallate blocks the induction of

nitric oxide synthase by down-regulating lipopolysaccharide-induced
 activity of transcription factor nuclear factor-Kb. Molecular Pharmacologi,
52: 465-472.

Lorenz M, Urban J (2009). Green and black tea are equally potent stimuli of NO
production and vasodilation: New insights into tea ingredients involved.
Basic research in cardiology, 104(1): 100-110.

Moningkey S (2000). Epidemiologi Kanker Payudara. Jakarta: Medika.

Naghma K, Afaq F, Saleem M, Ahmad N, and Mukhtar H (2006). Targeting

Multiple Signaling Pathways by Green Tea Polyphenol (-) Epigallocatechin-
3-Gallate. American Association for Cancer Research, 66(5):2500-2505.

Nakahara H, Howard L, Thompson EW, et al. (1997).

Ransmembrane/cytoplasmic domain-mediated membrane type 1-matrix
metalloprotease docking to invadopodia is required for cell invasion. Proc
Natl Acad Sci, 94: 7959–64.

Oktora L (2006). Pemanfaatan obat tradisional dengan pertimbangan manfaat dan

keamanannya. Majalah Ilmu Kefarmasian, 3(1): 1-7.

Pan MH, Huang TM, Lin JK (2011). Biotransformation of curcumin through

reduction and glucoronidation in mice. Institute of Biochemistry, College of
Medicine, National Taiwan University.

Pemerintah Provinsi Jawa Tengah (2003). Profil Kesehatan provinsi Jawa Tengah.

Robbins SL, Kumar V (2003). Cell Apoptosis. Basic Pathology. Edisi ke-7.
London: Saunders, pp: 9-10.

Roesli U (2010). Inisiasi Menyusu Dini plus ASI Ekslusif. Jakarta: Pustaka Bunda.

Salim M, Susanto A, Stefanus D (2014). ‘Terapi Nanopartikel Albumin-

Kurkumin Atasi Kanker Payudara Multidrug Resistant’ CDK-220/ vol. 41
no.9
Shao ZM, Shen ZZ, Liu CH, Sartippour MR (2001). Curcumin exerts multiple
suppressive effects on human breast carcinoma cells. IJC, 98(2): 234-240

Shiozaki T, sugiyama K (1997). Effect of tea extract, catechin, and caffeine

against type-1 allergic reaction. Yakugaku Zassshi, 112(7): 448-54.
Somers-Edgar TJ, Scandlyn MJ, Stuart MC, Nedelec MJL, Valentine SP,
Rosengren RJ (2008). The combination of epigallocatechin gallate and
curcumin suppresses ERa-breast cancer cell growth in vitro and in vivo.
2338_ftp. Int. J. Cancer:122,1966–1971.

Swart R, et al. (2010). Breast Cancer.

http://emedicine.medscape.com/article/283561-overview. Diakses Januari
2015.

Taufan N (2011). Asi dan Tumor Payudara. Yogyakarta: Nuha Medika.

Tiffany J. Somers, et al. (2008). ‘The combination of epigallocatechin gallate and

curcumin suppresses. ERa-breast cancer cell growth in vitro and in vivo’
Int. J. Cancer : 122

The Cancer Genome Atlas Network (2012). Comprehensive molecular portraits of

human breast tumors. Nature, 490(7418): 61-70.

WHO (2006). Guidelines for the early detection and Sscreening of breast cancer.
Egipt: Fikra advertising Agency.

WHO (2012). Population fact sheet. International agency for research on cancer.
http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Diakses Januari
2015.

Xiu-zu S, Zhi-gang BI, Ai-e X (2006). Green tea polyphenol epigallocatechin-3-

gallate inhibits the expression of nitric oxide synthase and generation of
nitric oxide induced by ultraviolet B in HaCaT cells. Chinese Medical
Journal, 119(4): 282-287.
Yang F, Villiers WJ, McClain CJ, Varilek GW (1998). Green tea polyphenols
block endotoxin-induced tumor necrosis factor-production and lethality in a
murine model. J Nutr, 128: 2334.